VANGUARD GROUP INC

Holdings History for TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

Symbol: TXMD on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	0%	$647,201	397,056	+20,228	+5.4%	$1.63	Q4 2025
30 Sep 2025	0%	0%	$399,437	376,828	-2,173	-0.57%	$1.06	Q3 2025
30 Jun 2025	0%	0%	$439,641	379,001	-2,941	-0.77%	$1.16	Q2 2025
31 Mar 2025	0%	0%	$353,297	381,942	-5,640		$0.93	Q1 2025
31 Dec 2024	0%	0%	$333,321	387,582	0		$0.86	Q4 2024
30 Sep 2024	0%	0%	$643,386	387,582	0		$1.66	Q3 2024
30 Jun 2024	0%	0%	$624,007	387,582	0		$1.61	Q2 2024
31 Mar 2024	0%	0%	$887,563	387,582	0		$2.29	Q1 2024
31 Dec 2023	0%	0%	$872,059	387,582	+2,334	+0.61%	$2.25	Q4 2023
30 Sep 2023	0%	0%	$1,163,449	385,248	0		$3.02	Q3 2023
30 Jun 2023	0%	0%	$1,587,221	385,248	0		$4.12	Q2 2023
31 Mar 2023	0%	0%	$1,444,680	385,248	0		$3.75	Q1 2023
31 Dec 2022	0%	+0%	$2,153,536	385,248	+124,837	+48%	$5.59	Q4 2022
30 Sep 2022	0%	-0%	$1,729,000	260,411	-105,383	-29%	$6.64	Q3 2022
30 Jun 2022	0%	+0%	$3,640,000	365,794	+365,794	NEW	$9.95	Q2 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.